Companies evaluating public markets are often presented with multiple options: a traditional IPO, a Regulation A offering, a reverse merger, a SPAC transaction, or a Canadian exchange listing. Each of these is a listing pathway - a distinct regulatory and transactional route to becoming a public company - and each carries very different implications for governance, cost, timeline, investor base, and long-term credibility. This article introduces a stage-based IPO readiness an

Recent analyses indicate a rebounding IPO environment, with technology and AI-related issuers leading activity and delivering strong aftermarket performance. High-quality companies demonstrating clear profitability paths, risk management and strategic clarity are attracting capital, while under-prepared offerings face scrutiny, delays and loss of investor confidence. For U.S. and Canadian listings, regulators (SEC and CSA) continue to deepen reviews of emerging risks, ie c

Nasdaq has signaled a decisive shift in how it intends to evaluate small-cap companies seeking to list. In its newly proposed rule change, the exchange is seeking enhanced discretionary power to deny listings - even when a company meets all current quantitative requirements. The objective is straightforward: strengthen investor protections, clamp down on manipulation risks, and increase confidence in small-cap issuers. For companies planning a capital markets event in 2026 an